A.I. Ally
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 22
- Inflammatory mediators and NSAID effects 20
- Pharmacogenetics and Drug Metabolism 3
- Physiology 13
- Nitric Oxide and Endothelin Effects 12
- Co-authors
- David F. Horrobin (27 shared papers)Reginald O. Morgan (26 shared papers)M.S. Manku (24 shared papers)Rashida A. Karmali (23 shared papers)Morris Karmazyn (23 shared papers)Stephen C. Cunnane (15 shared papers)Thomas E. Eling (4 shared papers)K. Nakatsu (1 shared paper)
- Journals
- Prostaglandins (6 papers)Canadian Journal of Physiology and Pharmacology (2 papers)Pharmacology Biochemistry and Behavior (2 papers)Environmental Health Perspectives (2 papers)Toxicology and Applied Pharmacology (2 papers)
- Partner nations
- CanadaUnited StatesSweden
In The Last Decade
A.I. Ally
43 papers receiving 878 citations
Peers
Comparison fields: 5 of 107
- Biochemistry 136
- Pharmacology 203
- Nutrition and Dietetics 126
- Cellular and Molecular Neuroscience 130
- Physiology 185
Countries citing papers authored by A.I. Ally
This map shows the geographic impact of A.I. Ally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.I. Ally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.I. Ally more than expected).
Fields of papers citing papers by A.I. Ally
This network shows the impact of papers produced by A.I. Ally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.I. Ally. The network helps show where A.I. Ally may publish in the future.
Co-authors
The 25 scholars most cited alongside A.I. Ally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 92 | |
| 2 | 1980 | 85 | |
| 3 | 1979 | 62 | |
| 4 | 1978 | 59 | |
| 5 | 1992 | 58 | |
| 6 | 1982 | 55 | |
| 7 | 1977 | 46 | |
| 8 | 1994 | 43 | |
| 9 | 1976 | 42 | |
| 10 | 1978 | 27 | |
| 11 | 1978 | 27 | |
| 12 | 1982 | 25 | |
| 13 | 1977 | 24 | |
| 14 | 1978 | 24 | |
| 15 | 1978 | 22 | |
| 16 | 1978 | 20 | |
| 17 | 1984 | 18 | |
| 18 | 1992 | 18 | |
| 19 | 1978 | 17 | |
| 20 | Regulation of cytoplasmic calcium: interactions between prostaglandins, prostacyclin, thromboxane A2, zinc, copper and taurine. | 1978 | 17 |
About A.I. Ally
A.I. Ally is a scholar working on Pharmacology, Physiology, Molecular Biology, Biochemistry and Cell Biology, having authored 43 papers that have together received 980 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (20 papers), Nitric Oxide and Endothelin Effects (12 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Neuroscience and Neuropharmacology Research (4 papers), Mercury impact and mitigation studies (3 papers), Receptor Mechanisms and Signaling (3 papers), Estrogen and related hormone effects (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Biochemistry (136 citations), Pharmacology (203 citations), Nutrition and Dietetics (126 citations), Cellular and Molecular Neuroscience (130 citations) and Physiology (185 citations). A.I. Ally has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include David F. Horrobin, Reginald O. Morgan, M.S. Manku, Rashida A. Karmali, Morris Karmazyn, Stephen C. Cunnane, Thomas E. Eling, K. Nakatsu, Bruce A. Pappas and Beth Tainer. Their work appears in journals such as Prostaglandins, Canadian Journal of Physiology and Pharmacology, Pharmacology Biochemistry and Behavior, Environmental Health Perspectives and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.